Uterine Cancer Therapies and Diagnostic Market, By Type (Endometrial carcinomas, Uterine sarcomas), By Treatment (Immunotherapy, Surgery, Chemotherapy, Follow-up Treatment, Radiation therapy), By Major Tests (Hysteroscopy, Biopsy, Pelvic Ultrasound, CT Scan, Dilation and curettage, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Uterine cancer therapies and diagnostic market size was valued at USD 22,061.9 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.
Uterine cancer, also known as endometrial cancer, is a type of malignancy that originates in the cells of the uterus, which is a crucial component of the female reproductive system. This cancerous growth possesses the capability to metastasize to different regions of the body. The field of uterine cancer therapeutics encompasses a wide array of treatment approaches, including radiation therapy, hormone therapy, targeted therapy, chemotherapy, and surgical intervention. Furthermore, the selection of an appropriate treatment strategy hinges upon several determinants, such as the patient\'s overall health, the specific type of uterine cancer, and the stage of advancement of the disease.
Uterine Cancer Therapies and Diagnostic Market- Market Dynamics
- Awareness of uterine cancer and technical innovations are expected to drive market growth
Increasing awareness among healthcare providers and patients regarding the prevalence of uterine cancer and the available treatment options is a pivotal driving force in the global market for uterine cancer therapies and diagnostics. However, this market faces challenges such as expensive treatment procedures and potential adverse effects. On a positive note, the growth of this market is propelled by a substantial rise in healthcare expenditure, particularly among urban communities, and government initiatives aimed at improving healthcare infrastructure. Furthermore, the introduction of technological innovations in healthcare services and the development of novel drugs for uterine cancer have encouraged patients to seek proper diagnostics and treatments.
Uterine Cancer Therapies and Diagnostic Market- Key Insights
- According to insights provided by our research analyst, the global market for uterine cancer therapies and diagnostics is anticipated to experience substantial growth, with an estimated annual CAGR of approximately 6.3% throughout the forecast period from 2023 to 2030.
- The driving force behind this growth is the increasing prevalence of endometrial adenocarcinoma, a specific type of uterine cancer.
- In terms of market segments, endometrial carcinomas claimed the largest market share in 2022, particularly within the realm of type segmentation, while chemotherapy emerged as the leading treatment type during the same year.
- The surge in obesity rates among women is a primary contributing factor to the rising incidence of endometrial carcinoma, further propelling market expansion.
Uterine Cancer Therapies and Diagnostic Market- Segmentation Analysis:
The global market for uterine cancer therapies and diagnostics is structured around key categories, including type, treatment, major tests, and geographical regions. Among these divisions, the endometrial carcinomas category is poised to assert its dominance, occupying a significant market share throughout the forecast period.
Endometrial carcinoma represents a unique form of uterine cancer that manifests in the uterine lining. Advancements in diagnostic methodologies and tools, particularly those tailored for the precise detection and assessment of endometrial carcinomas, are instrumental in shaping the diagnostic market within this specific segment. Cutting-edge technologies such as liquid biopsies and state-of-the-art imaging solutions play a vital role in advancing diagnostics for endometrial carcinomas.
Uterine Cancer Therapies and Diagnostic Market- Geographical Insights
The future landscape of the uterine cancer therapeutics and diagnostics market points towards North America as the dominant force. This ascendancy can be attributed to the increasing awareness and a surge in uterine cancer cases among the general population. Furthermore, the rapid adoption of cutting-edge technologies within the regional economy serves as a catalyst, propelling the overall market growth.
Uterine Cancer Therapies and Diagnostic Market- Competitive Landscape:
The uterine cancer therapeutic and diagnostic market is marked by intense competition, featuring a multitude of medical device manufacturers, pharmaceutical companies, and research institutions actively engaging in the sector. The continuous evolution of diagnostic and therapeutic technologies, coupled with the entry of new players, has a profound impact on the market dynamics.
Furthermore, government initiatives and healthcare policies aimed at supporting cancer treatment and screening serve as significant drivers for the overall growth of the uterine cancer therapeutic and diagnostic market. In the realm of oncology, ongoing research and development activities are instrumental in the creation of advanced diagnostic tools and innovative therapies. For example, in June 2023, Pfizer Inc. announced the reavailability of DUAVEE®, an estrogen-based menopause hormone therapy, in the United States, featuring improved packaging, following a voluntary recall driven by packaging concerns and not related to product safety or efficacy issues.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET KEY PLAYERS
- Ariad Pharmaceuticals
- AstraZeneca PLC
- Siemens Healthcare Inc.
- Abbott Laboratories
- Eli Lilly and Company
- Becton Dickinson & co
- Roche Ltd.
- GlaxoSmithKline Plc
- Ability Pharma
- Merck & Co.
- BioMerieux S.A.
- Novartis AG
- Hoffmann-La Roche AG
- Sanofi
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TYPE
- Endometrial carcinomas
- Uterine sarcomas
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TREATMENT
- Immunotherapy
- Surgery
- Chemotherapy
- Follow-up Treatment
- Radiation therapy
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY MAJOR TESTS
- Hysteroscopy
- Biopsy
- Pelvic Ultrasound
- CT Scan
- Dilation and curettage
- Others
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Uterine Cancer Therapies and Diagnostic Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Uterine Cancer Therapies and Diagnostic Market Snippet by Type
2.1.2. Uterine Cancer Therapies and Diagnostic Market Snippet by Treatment
2.1.3. Uterine Cancer Therapies and Diagnostic Market Snippet by Major tests
2.1.4. Uterine Cancer Therapies and Diagnostic Market Snippet by Country
2.1.5. Uterine Cancer Therapies and Diagnostic Market Snippet by Region
2.2. Competitive Insights
3. Uterine Cancer Therapies and Diagnostic Key Market Trends
3.1. Uterine Cancer Therapies and Diagnostic Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Uterine Cancer Therapies and Diagnostic Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Uterine Cancer Therapies and Diagnostic Market Opportunities
3.4. Uterine Cancer Therapies and Diagnostic Market Future Trends
4. Uterine Cancer Therapies and Diagnostic Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Uterine Cancer Therapies and Diagnostic Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Uterine Cancer Therapies and Diagnostic Market Landscape
6.1. Uterine Cancer Therapies and Diagnostic Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Uterine Cancer Therapies and Diagnostic Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
7.1.2. Endometrial carcinomas
7.1.3. Uterine sarcomas
8. Uterine Cancer Therapies and Diagnostic Market – By Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
8.1.2. Immunotherapy
8.1.3. Surgery
8.1.4. Chemotherapy
8.1.5. Follow-up Treatment
8.1.6. Radiation therapy
9. Uterine Cancer Therapies and Diagnostic Market – By Major tests
9.1. Overview
9.1.1. Segment Share Analysis, By Major tests, 2022&2030 (%)
9.1.2. Hysteroscopy
9.1.3. Biopsy
9.1.4. Pelvic Ultrasound
9.1.5. CT Scan
9.1.6. Dilation and curettage
10. Uterine Cancer Therapies and Diagnostic Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Uterine Cancer Therapies and Diagnostic Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Ariad Pharmaceuticals
11.2.2. AstraZeneca PLC
11.2.3. Siemens Healthcare Inc.
11.2.4. Abbott Laboratories
11.2.5. Eli Lilly and Company
11.2.6. Becton Dickinson & co
11.2.7. Roche Ltd.
11.2.8. GlaxoSmithKline Plc
11.2.9. Ability Pharma
11.2.10. Merck & Co.
11.2.11. BioMerieux S.A.
11.2.12. Novartis AG
11.2.13. F. Hoffmann-La Roche AG
11.2.14. Sanofi
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
